Corporate News     26-Dec-20
Biocon update on Biologics License Application for MYL-1402O (bevacizumab)
Biocon Biologics, a subsidiary of Biocon and Mylan (a subsidiary of Viatris Inc.) have been informed by the U.S. Food and Drug Administration (FDA) of a deferred action on the Biologics License Application (BLA) for MYL-1402O, a proposed biosimilar to Avastin® (bevacizumab).

To complete the application, the Agency noted that an inspection of the manufacturing facility is required as a part of the standard review process. However, due to restrictions on travel related to COVID-19, the Agency is unable to conduct an inspection during the current review cycle.

There are no additional observations related to the application.

Previous News
  Benchmarks trade falt; oil & gas shares rally for 9th day in row
 ( Market Commentary - Mid-Session 24-May-24   12:33 )
  Biocon Ltd spurts 1.22%, gains for third straight session
 ( Hot Pursuit - 07-Jun-24   13:05 )
  Biocon Ltd spurts 0.58%, gains for fifth straight session
 ( Hot Pursuit - 04-Jan-24   13:00 )
  Biocon rallies after recording PAT of Rs 126 cr in Q2 FY24
 ( Hot Pursuit - 12-Nov-23   18:17 )
  Biocon surges after signing exclusive licensing deal for Liraglutide with Handok
 ( Hot Pursuit - 24-May-24   09:45 )
  Biocon gains after arm inks distribution agreement with Sandoz
 ( Hot Pursuit - 26-Dec-23   10:40 )
  Biocon Biologics strengthens its leadership team
 ( Corporate News - 04-Aug-23   16:05 )
  Biocon to declare Quarterly Result
 ( Corporate News - 24-Apr-23   11:48 )
  Biocon gains as arm takes over Viatris' biosimilar biz in over 70 countries
 ( Hot Pursuit - 06-Jul-23   12:03 )
  Biocon Ltd spurts 0.71%, rises for fifth straight session
 ( Hot Pursuit - 19-Jun-23   13:00 )
  Biocon slips after reporting net loss of Rs 42 cr in Q3
 ( Hot Pursuit - 15-Feb-23   11:58 )
Other Stories
  Board of Delhivery approves alteration in capital clause of MoA
  05-Jul-24   19:32
  J B Chemicals & Pharmaceuticals appoints director
  05-Jul-24   19:30
  Infosys announces resignation of senior management personnel
  05-Jul-24   19:22
  JLR Q1 FY25 retail sales up 9% on YoY basis
  05-Jul-24   19:08
  Bajaj Auto launches world's first CNG motorcycle 'Freedom'
  05-Jul-24   18:59
  Agenda for board meeting of Power Grid Corporation of India
  05-Jul-24   18:46
  Board of Bank of Baroda approves raising additional capital up to Rs 7,500 cr in FY25
  05-Jul-24   18:06
  Vipul to hold board meeting
  05-Jul-24   17:15
  Markobenz Ventures to convene board meeting
  05-Jul-24   17:15
  Dhanashree Electronics to declare Quarterly Result
  05-Jul-24   17:15
Back Top